Accession | ARO:3007565 |
Definition | Aspergillus spp. cyp51A is a fungal cytochrome P450 enzyme with mutations in the gene causing triazole resistance. |
AMR Gene Family | triazole-resistant fungal cytochrome P450 enzyme |
Drug Class | triazole antibiotic |
Resistance Mechanism | antibiotic target alteration |
Classification | 10 ontology terms | Show + process or component of antibiotic biology or chemistry + mechanism of antibiotic resistance + antibiotic target alteration [Resistance Mechanism] + mutation conferring antibiotic resistance + determinant of antibiotic resistance + antibiotic molecule + azole antibiotic + antibiotic resistant gene variant or mutant + antifungal-resistant cytochrome P450 enzyme + triazole antibiotic [Drug Class] |
Parent Term(s) | 4 ontology terms | Show + confers_resistance_to_antibiotic itraconazole [Antibiotic] + confers_resistance_to_antibiotic voriconazole [Antibiotic] + confers_resistance_to_antibiotic posaconazole [Antibiotic] + triazole-resistant fungal cytochrome P450 enzyme [AMR Gene Family] |
Publications | Mellado E, et al. 2004. Antimicrob Agents Chemother 48(7):2747-50 Substitutions at methionine 220 in the 14alpha-sterol demethylase (Cyp51A) of Aspergillus fumigatus are responsible for resistance in vitro to azole antifungal drugs. (PMID 15215142) Diaz-Guerra TM, et al. 2003. Antimicrob Agents Chemother 47(3):1120-4 A point mutation in the 14alpha-sterol demethylase gene cyp51A contributes to itraconazole resistance in Aspergillus fumigatus. (PMID 12604551) |
Private model - RGI is not currently using this model.